These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7797277)

  • 1. Serum zinc levels in hepatic encephalopathy.
    Loomba V; Pawar G; Dhar KL; Setia MS
    Indian J Gastroenterol; 1995 Apr; 14(2):51-3. PubMed ID: 7797277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Zinc Level in Decompensated Liver Disease and its Correlation with Stage of Hepatic Encephalopathy.
    Meena RK; G S; Saravanan P; P K; Ramadoss K; A V
    J Assoc Physicians India; 2019 Jan; 67(1):30-32. PubMed ID: 30935169
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observation.
    Udayakumar N; Subramaniam K; Umashankar L; Verghese J; Jayanthi V
    J Clin Gastroenterol; 2007; 41(10):922-6. PubMed ID: 18090162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc abnormalities in fulminant hepatic failure.
    Canalese J; Sewell RB; Poston L; Williams R
    Aust N Z J Med; 1985 Feb; 15(1):7-9. PubMed ID: 3859271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of zinc in subclinical hepatic encephalopathy: comparison with somatosensory-evoked potentials.
    Yang SS; Lai YC; Chiang TR; Chen DF; Chen DS
    J Gastroenterol Hepatol; 2004 Apr; 19(4):375-9. PubMed ID: 15012773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical studies on zinc in chronic liver diseases.
    Grüngreiff K; Abicht K; Kluge M; Presser HJ; Franke D; Kleine FD; Klauck S; Diete U
    Z Gastroenterol; 1988 Aug; 26(8):409-15. PubMed ID: 3218283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum gamma-aminobutyric acid (GABA) levels in patients with hepatic encephalopathy.
    Minuk GY; Winder A; Burgess ED; Sarjeant EJ
    Hepatogastroenterology; 1985 Aug; 32(4):171-4. PubMed ID: 4054811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin in acute and subacute hepatic failure.
    Anand AC; Irshad M; Acharya SK; Gandhi BM; Joshi YK; Tandon BN
    J Clin Gastroenterol; 1989 Jun; 11(3):314-9. PubMed ID: 2754218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum concentration of zinc in patients with liver cirrhosis with and without chronic hepatic encephalopathy. Results of a prospective study].
    Garcia-Compean D; Perez-Martinez C; Cuellar JA; Barragan RF; Piñeyro Lopez A
    Gastroenterol Clin Biol; 1994; 18(3):295-6. PubMed ID: 7926452
    [No Abstract]   [Full Text] [Related]  

  • 10. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom.
    Lee WS; McKiernan P; Kelly DA
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):575-81. PubMed ID: 15861019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and urinary copper in acute hepatic encephalopathy.
    Singh V; Bhattacharya SK; Sunder S; Kachhawaha JS
    J Assoc Physicians India; 1990 Jul; 38(7):467-9. PubMed ID: 2292550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant Wilson's disease in children: appraisal of a critical diagnosis.
    Tissières P; Chevret L; Debray D; Devictor D
    Pediatr Crit Care Med; 2003 Jul; 4(3):338-43. PubMed ID: 12831417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure.
    Odeh M; Sabo E; Srugo I; Oliven A
    Liver Int; 2004 Apr; 24(2):110-6. PubMed ID: 15078474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B.
    Yang SS; Cheng KS; Lai YC; Wu CH; Chen TK; Lee CL; Chen DS
    J Gastroenterol; 2002; 37(8):626-32. PubMed ID: 12203078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and urinary zinc in fulminant hepatic failure.
    Nandi SS; Chawla YK; Nath R; Dilawari JB
    J Gastroenterol Hepatol; 1989; 4(3):209-13. PubMed ID: 2518804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut hormone profile of fulminant hepatic failure.
    Sullivan SN; Chase RA; Christofides ND; Bloom SR; Williams R
    Am J Gastroenterol; 1981 Oct; 76(4):338-41. PubMed ID: 7325145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure.
    Hsu CY; Lee FY; Huo TI; Chan CY; Huang HC; Lin HC; Chang CC; Teng TH; Wang SS; Lee SD
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1321-8. PubMed ID: 20594263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate prediction of fulminant hepatic failure in severe acute viral hepatitis: multicenter study.
    Yoshiba M; Sekiyama K; Inoue K; Yamada M; Kako M; Nagai K; Takatori M; Iwabuchi S; Sumino Y; Tanaka K; Hakozaki Y; Hasegawa K; Shibuya A
    J Gastroenterol; 2002; 37(11):916-21. PubMed ID: 12501858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial.
    Reding P; Duchateau J; Bataille C
    Lancet; 1984 Sep; 2(8401):493-5. PubMed ID: 6147551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher Grades and Repeated Recurrence of Hepatic Encephalopathy May Be Related to High Serum Manganese Levels.
    Kobtan AA; El-Kalla FS; Soliman HH; Zakaria SS; Goda MA
    Biol Trace Elem Res; 2016 Feb; 169(2):153-8. PubMed ID: 26129828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.